Consistent with these findings, previous studies have reported the anti-inflammatory effects of pharmacological stimulation with sGC enzyme in various experimental models of tissue fibrosis and inflammation, such as non-alcoholic steatohepatitis and the Dahl model of cardiorenal failure [54,55,56]. The gene discussed is SGCB; the disease is metabolic dysfunction-associated steatohepatitis.